PSMA PET/CT in the low- to intermediate-risk prostate cancer: when and why? by Luca Sofia, Matteo Bauckneht

Get full text

Diagnostic value of dual-tracer PET/CT with [18F]FDG and PSMA ligands in prostate cancer: an updated systematic review by Cesare Michele Iacovitti, Marco Cuzzocrea, Alessio Rizzo, Matteo Bauckneht, Matteo Bauckneht, Roberto C. Delgado Bolton, Roberto C. Delgado Bolton, Gaetano Paone, Gaetano Paone, Giorgio Treglia, Giorgio Treglia, Giorgio Treglia

Get full text

Soluble Co‐Inhibitory Immune Checkpoint Molecules Are Increased in Patients With Polymyalgia Rheumatica Without Significant Correlations With Clinical Status: A Case‐Control Study... by Elvis Hysa, Dario Camellino, Christian Dejaco, Matteo Bauckneht, Giampaola Pesce, Silvia Morbelli, Marcello Bagnasco, Maurizio Cutolo, Eric L. Matteson, Marco A. Cimmino, Daniele Saverino

Get full text

[18F]Tetrafluoroborate, a new NIS PET/CT radiopharmaceutical: an overview focused on differentiated thyroid cancer by Arnoldo Piccardo, Francesco Fiz, Sergio Righi, Stefano Raffa, Mattia Riondato, Gianluca Bottoni, Matteo Bauckneht, Michela Massollo, Alessio Rizzo, Mehrdad Shoushtari Zadeh Naseri, Pierpaolo Trimboli, Giorgio Treglia

Get full text

Increased [¹⁸F]DPA-714 Uptake in the Skeletal Muscle of SOD1^G93A Mice: A New Potential of Translocator Protein 18 kDa Imaging in Amyotrophic Lateral Sclerosis by Cecilia Marini, Mattia Riondato, Edoardo Dighero, Alessia Democrito, Serena Losacco, Laura Emionite, Lucilla Nobbio, Irene Di Patrizi, Mattia Camera, Chiara Ghersi, Maddalena Ghelardoni, Francesco Lanfranchi, Francesca Vitale, Sonia Carta, Sabrina Chiesa, Carola Torazza, Marco Milanese, Matteo Bauckneht, Mehrnaz Hamedani, Federico Zaottini, Angelo Schenone, Carlo Martinoli, Federica Grillo, Gianmario Sambuceti

Get full text